Michael Camilleri, M.D., D.Sc., has been a Mayo Clinic physician since 1990 with an active laboratory to study human gastrointestinal motility and sensation in health and disease in addition to the role of the gastrointestinal tract in obesity (>700 original, peer-reviewed articles since 1987, including 70 pertaining to obesity). He has been funded by multiple NIH RO1 grants as well as a K24 grant from NIH for >20 years.
Dr. Camilleri's received his NIH funding to study the role of gastric function, incretins, behavioral and psychological aspects of obesity, as well as the effects of pharmacological agents and impact of genetic variations in pivotal pathways of relevance to obesity and type 2 diabetes mellitus. Through diverse methods (many of them developed in his lab at Mayo Clinic), Dr. Camilleri studies gastrointestinal diseases that arise within the gut itself, as well as diseases in which the gastrointestinal tract is secondarily affected by conditions such as diabetes mellitus, scleroderma and neurological diseases.
His research continues to improve patient care by contributing to the development of novel and often noninvasive diagnostic tools to replace invasive and less accurate or less specific diagnostics; demonstrating proof of efficacy of new medications; participating in multi-center clinical trials; identifying beneficial or deleterious effects of dietary factors; and developing individualized treatments in obesity based on medications that target dysfunctions of stomach and appetite and the genes that modify these functions.
Dr. Camilleri has received numerous awards and honors including the 2012 Ismar Boas Medal from the German Society of Digestive and Metabolic Disease, the 2012 AGA Distinguished Mentor Award, the Janssen Research Award, the AGA Joseph B. Kirsner Award, and the AGA Julius Friedenwald Medal in 2021. He is a member of the Association of American Physicians, has an Endowed Professorship at Mayo Clinic (Atherton and Winifred W. Bean Professor of Medicine, Physiology and Pharmacology), and is currently associate editor of the journal GUT.
He was previously an editor of Clinical Gastroenterology and Hepatology, Neurogastroenterology and Motility, associate editor of Gastroenterology and American Journal of Physiology (GI). He was also a former member of NIH study sections CIPB and DDK-C Special Review Subcommittee for Digestive Diseases and Nutrition, past president of the American Gastroenterological Association, American Neurogastroenterology and Motility Society, and has served as a member and Chair of the FDA Advisory Committee on GI Drugs.
